We monitored the levels of VEGF, GLUT1 and CA-IX as markers of HIF activation in the surgical resection samples, as previously (22, 37) and have compared tumor and adjacent normal mucosal tissue in control and infusion patient samples. The gene discussed is SLC2A1; the disease is neoplasm.